GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmsynthez PJSC (MIC:LIFE) » Definitions » Change In Receivables

Pharmsynthez PJSC (MIC:LIFE) Change In Receivables : ₽-29.1 Mil (TTM As of Jun. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Pharmsynthez PJSC Change In Receivables?

Pharmsynthez PJSC's change in receivables for the quarter that ended in Jun. 2023 was ₽-73.2 Mil. It means Pharmsynthez PJSC's Accounts Receivable increased by ₽73.2 Mil from Dec. 2022 to Jun. 2023 .

Pharmsynthez PJSC's change in receivables for the fiscal year that ended in Dec. 2022 was ₽9.9 Mil. It means Pharmsynthez PJSC's Accounts Receivable declined by ₽9.9 Mil from Dec. 2021 to Dec. 2022 .

Pharmsynthez PJSC's Accounts Receivable for the quarter that ended in Jun. 2023 was ₽214.8 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Pharmsynthez PJSC's Days Sales Outstanding for the six months ended in Jun. 2023 was 227.36.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Pharmsynthez PJSC's liquidation value for the six months ended in Jun. 2023 was ₽-617.9 Mil.


Pharmsynthez PJSC Change In Receivables Historical Data

The historical data trend for Pharmsynthez PJSC's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmsynthez PJSC Change In Receivables Chart

Pharmsynthez PJSC Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -57.19 74.10 15.76 9.86

Pharmsynthez PJSC Semi-Annual Data
Dec11 Jun13 Dec13 Jun14 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.39 37.15 -34.23 44.08 -73.19

Pharmsynthez PJSC Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₽-29.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmsynthez PJSC  (MIC:LIFE) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Pharmsynthez PJSC's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=214.849/172.46*91
=227.36

2. In Ben Graham's calculation of liquidation value, Pharmsynthez PJSC's accounts receivable are only considered to be worth 75% of book value:

Pharmsynthez PJSC's liquidation value for the quarter that ended in Jun. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=257.062-1078.653+0.75 * 214.849+0.5 * 85.061
=-617.9

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmsynthez PJSC Change In Receivables Related Terms

Thank you for viewing the detailed overview of Pharmsynthez PJSC's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmsynthez PJSC (MIC:LIFE) Business Description

Traded in Other Exchanges
N/A
Address
150 Engelsa Prospect, St. Petersburg, RUS, 194358
Pharmsynthez PJSC is a pharmaceutical company developing new medications, technologies of drugs for organ-specific delivery and innovative methods of manufacture for pharmaceutical ingredients. The company is engaged in the research and development, production and sales of officinal medicines (original OM) and active pharmaceutical ingredients (API).

Pharmsynthez PJSC (MIC:LIFE) Headlines

No Headlines